i and solutions Revenue and Competitors

Woerden, Netherlands

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • i and solutions's estimated annual revenue is currently $52M per year.(i)
  • i and solutions's estimated revenue per employee is $360,800

Employee Data

  • i and solutions has 144 Employees.(i)
  • i and solutions grew their employee count by 30% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$137.4M33521%N/AN/A
#2
$163.6M3997%N/AN/A
#3
$11.3M43-34%N/AN/A
#4
$53M147-23%N/AN/A
#5
$21.5M731%N/AN/A
#6
$247.2M60343%$78.2MN/A
#7
$356.8M777-4%N/AN/A
#8
$356.8M777-4%N/AN/A
#9
$0.7M4N/AN/AN/A
#10
$3.3M176%N/AN/A
Add Company

What Is i and solutions?

i+solutions’ vision is a world where all medical unmet needs are addressed with innovative solutions. Our mission is to save and improve lives by creating well-functioning health supply chains, ensuring all have access to affordable quality medicines and health care when needed. \ni+solutions is the leading procurement service agent (PSA) for HIV, TB, and malaria treatments, PPE and oxygen plants under the Global Fund’s Pooled Procurement Mechanism and StopTB Partnership/UNOPS' GDF project. i+solutions also works as PSA for other global donors and local governments. i+solutions offers 4PL and market access services to pharmaceutical companies who seek help to introduce their products in complex markets. i+solutions drives an innovative agenda to improve global health supply chains and combines procurement, training, project management, quality assurance and technical expertise to make a difference from the first to the last mile, closing the gap between patient and medicine. Impact by innovation.\n\ni+solutions is a foundation, based in Woerden, The Netherlands.

keywords:N/A

N/A

Total Funding

144

Number of Employees

$52M

Revenue (est)

30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$26.2M170-17%N/A
#2
$26.2M170-17%N/A
#3
$29M182-1%N/A
#4
N/A2176%N/A
#5
$45.9M2887%N/A